Search results for "Keeping tabs"
Spotlight on the diabetic foot
Recent diabetes research analyzed trends in lower-extremity amputations in Ontario, Canada, as well as how health literacy, procalcitonin, and mortality risk relate to diabetic foot infection outcomes.
https://diabetes.acponline.org/archives/2019/09/13/5.htm
13 Sep 2019
Spotlight on the gut microbiome
A Finnish study found that certain gut bacteria were more common in people who later developed type 2 diabetes, while an Israeli study identified a distinct microbial signature in adults with type 1 diabetes compared with healthy controls.
https://diabetes.acponline.org/archives/2022/02/11/5.htm
11 Feb 2022
Spotlight on inpatient hyperglycemia
A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
https://diabetes.acponline.org/archives/2022/07/08/5.htm
8 Jul 2022
Spotlight on response to hypoglycemia
Recent studies looked at how low serum glucose levels in ambulatory patients are handled, what happens after a hospital visit for hypoglycemia, and the state of research on deprescribing in patients with diabetes.
https://diabetes.acponline.org/archives/2020/10/09/5.htm
9 Oct 2020
Spotlight on the value of care
One recent study found overtreatment of type 2 diabetes among elderly patients, while another looked at how many patients with diabetes would be referred to a liver specialist under proposed European guidelines.
https://diabetes.acponline.org/archives/2018/02/09/5.htm
9 Feb 2018
Spotlight on the effects of exercise in diabetes
Studies published in the past month looked at how exercise and indicators of fitness among patients with diabetes are associated with mortality risk, vascular health, and medication use.
https://diabetes.acponline.org/archives/2020/02/14/5.htm
14 Feb 2020
Spotlight on SGLT-2 inhibitors and heart failure
The effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on heart failure, in patients with and without diabetes, were the focus of three analyses published in the past month, two on dapagliflozin and one on canagliflozin.
https://diabetes.acponline.org/archives/2019/10/11/5.htm
11 Oct 2019